Towards Healthcare

News

Your marketplace is evolving, your competitors are readjusting – but instead of reacting you can proact

Moffitt Cancer Center Partners with PathAI to Advance Digital Pathology and AI in Cancer Care
26 August 2025

Moffitt Cancer Center Partners with PathAI to Advance Digital Pathology and AI in Cancer Care

Moffitt and PathAI’s Partnership to Initiate Digitalization Announcement PathAI, a known leader in digital pathology solutions and artificial intelligence, entered a multi-year partnership with Moffitt Cancer Center, one of the popular cancer hospitals and a global leader in cancer researc...

Invivyd Prices Public Offering of Common Stock and Pre-Funded Warrants to Raise $50 Million
25 August 2025

Invivyd Prices Public Offering of Common Stock and Pre-Funded Warrants to Raise $50 Million

Invivyd Priced its Public Offering of Common Stock and Pre-funded Warrants in Millions Announcement Invivyd Inc. has revealed the pricing of an underwritten public offering of 74,811,404 shares of its common stock at a price of the offering by $0.52 per share for specific investors instead of co...

LinusBio Launches ClearStrand-ASD Autism Screening Test in Japan
25 August 2025

LinusBio Launches ClearStrand-ASD Autism Screening Test in Japan

LinusBio’s ClearStrand-ASD has Entered Japan Announcement LinusBio, a popular player in precision exposome medicine, proudly declared that Clearstrand-ASD, its biochemical autism screening test, is available in Japan for research purposes via a partnership with YAC bio. This successful ste...

CORL Technologies Partners with Mastercard’s RiskRecon to Strengthen Healthcare Cybersecurity
25 August 2025

CORL Technologies Partners with Mastercard’s RiskRecon to Strengthen Healthcare Cybersecurity

CORL Technologies and RiskRecon by Mastercard Entered into a Partnership for a Strong Purpose Announcement CORL Technologies, the leading healthcare company managing third-party risk management (TPRM) solutions, has entered a partnership with Mastercard.  The partnership will merge Masterca...

FDA Grants Priority Review for Rhythm Pharmaceuticals’ Setmelanotide in Hypothalamic Obesity
25 August 2025

FDA Grants Priority Review for Rhythm Pharmaceuticals’ Setmelanotide in Hypothalamic Obesity

FDA Approved Rhythm’s sNDA Announcement Rhythm Pharmaceuticals Inc., a leading commercial-stage biopharmaceutical company aiming to change the lives of patients with rare neuroendocrine disease, has been given permission to file the supplemental new drug application (sNDA) for setmelanotid...

Pharmaceutical Sterile Sample Bags Market 2025 Driving Pharmaceutical Quality Standards
22 August 2025

Pharmaceutical Sterile Sample Bags Market 2025 Driving Pharmaceutical Quality Standards

Pharmaceutical Sterile Sample Bags Market Driving Next-Gen Pharma Safety According to Towards Packaging, the global pharmaceutical sterile sample bags market size was estimated at USD 1.50 billion in 2024 and is anticipated to reach around USD 1.88 billion by 2034, growing at a CAGR of 2.27 ...

Aprecia and Battelle Partner with DARPA and HHS for Agile Pharmaceutical Manufacturing
22 August 2025

Aprecia and Battelle Partner with DARPA and HHS for Agile Pharmaceutical Manufacturing

Aprecia and Battelle Partnered with the US Department of HHS and DARPA Announcement Aprecia and Battelle were granted a chance to collaborate with the US Defense Advanced Research Projects Agency (DARPA) as an award agreement to fuel the research program named ‘Establishing Qualification P...

Rady Children’s Institute Partners with Sidra Medicine to Launch Global Newborn Genome Screening
22 August 2025

Rady Children’s Institute Partners with Sidra Medicine to Launch Global Newborn Genome Screening

Rady to Enter an International Partnership with Sidra Medicine Announcement Rady Children’s Institute for Genomic Medicine (RCIGM) entered into a collaboration with Sidra Medicine, an excellent specialty healthcare organization for women, young people, and children in the state of Qatar. T...

Biotechs Adopt ‘Two-in-One’ Strategy to Target Multiple Diseases
22 August 2025

Biotechs Adopt ‘Two-in-One’ Strategy to Target Multiple Diseases

Biotechs Pursue a ‘Target Two Objectives With One Solution’ Strategy The History that Led to a Change in the Strategy From 2012 to 2020, AbbVie’s Humira, an excellent I and I, ranked as the most effective drug globally. The sales bar hit the growth level in 2022 in the times wh...

SkinMedica Launches HA5 Hydra Collagen Hydrating Foaming Cleanser for Deep Hydration
22 August 2025

SkinMedica Launches HA5 Hydra Collagen Hydrating Foaming Cleanser for Deep Hydration

SkinMedica® Reveals its Secret Hydration Formula Announcement Allergan Aesthetics, an AbbVie company, revealed its new addition to its SkinMedica HA5 hydra collagen portfolio. Focusing on the brand’s exclusivity, HA5 hydra collagen complex, a mixture of five forms of hyaluronic acid an...